<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR24">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Roth</surname>
    <given-names>EM</given-names>
   </name>
   <name>
    <surname>Diller</surname>
    <given-names>P</given-names>
   </name>
  </person-group>
  <article-title>Alirocumab for hyperlipidemia: physiology of PCSK9 inhibition, pharmacodynamics and Phase I and II clinical trial results of a PCSK9 monoclonal antibody</article-title>
  <source>Futur Cardiol</source>
  <year>2014</year>
  <volume>10</volume>
  <fpage>183</fpage>
  <lpage>199</lpage>
  <pub-id pub-id-type="doi">10.2217/fca.13.107</pub-id>
 </element-citation>
</ref>
